Amanote Research
Register
Sign In
HDAC Inhibitors Show Benefits in Breast Cancer
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-nd112311ol-07
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
November 23, 2011
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
New and Emerging HDAC Inhibitors for Cancer Treatment
Journal of Clinical Investigation
Medicine
Understanding Failure and Improving Treatment Using HDAC Inhibitors for Prostate Cancer
Biomedicines
Biochemistry
Medicine
Genetics
Molecular Biology
Comparison of HDAC Inhibitors in Clinical Development
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
HDAC Inhibitors in Experimental Liver and Kidney Fibrosis
Fibrogenesis and Tissue Repair
Dermatology
Medicine
Hepatology
Rheumatology
Gastroenterology
Differential Response of Cancer Cells to HDAC Inhibitors Trichostatin a and Depsipeptide
British Journal of Cancer
Cancer Research
Oncology
Identification of HDAC Inhibitors Using a Cell-Based HDAC I/Ii Assay
Journal of Biomolecular Screening
Molecular Medicine
Pharmacology
Biochemistry
Analytical Chemistry
Biotechnology
Drug Discovery
Costs and Benefits of Diagnosing Familial Breast Cancer
Disease Markers
Biochemistry
Medicine
Clinical Biochemistry
Molecular Biology
Genetics
Novel Thioredoxin Inhibitors for Breast Cancer Therapy
HDAC Inhibitors Stimulate Viral Transcription by Multiple Mechanisms
Virology Journal
Virology
Infectious Diseases